# CXCL6

## Overview
CXCL6, or C-X-C motif chemokine ligand 6, is a gene that encodes a protein known as granulocyte chemotactic protein 2 (GCP-2), which is a member of the CXC chemokine family. This protein plays a pivotal role in the immune system by mediating the recruitment and activation of neutrophils, thereby contributing to the innate immune response. CXCL6 is characterized by its CXC motif, which is crucial for its structural stability and function, including its antibacterial activity. The protein interacts with CXCR1 and CXCR2 receptors, facilitating chemotaxis and cellular activation. Beyond its role in immune response, CXCL6 is involved in angiogenesis and has been implicated in various pathological conditions, including cancer and inflammatory diseases, where it influences cell proliferation, migration, and survival (mittal2008cxcl6; Linge2008The; Zhou2023The).

## Structure
The CXCL6 protein, also known as granulocyte chemotactic protein 2 (GCP-2), is a member of the CXC chemokine family and exhibits a specific molecular structure that contributes to its antibacterial activity. The primary structure of CXCL6 includes a typical CXC motif, which forms disulfide bonds between cysteines at positions 12 to 38 and 14 to 54, essential for its stability and function (Linge2008The). The secondary structure is characterized by an NH2 terminus that is likely unstructured, followed by three antiparallel β-sheets and a short α-helix. The COOH-terminal region is predicted to be an α-helix with amphipathic features, containing both hydrophobic and hydrophilic amino acids arranged in a polarized fashion (Linge2008The).

The tertiary structure involves the overall folding of these elements, stabilized by the disulfide bonds, which are crucial for maintaining the protein's conformation and function (Linge2008The). Although the quaternary structure is not explicitly detailed, the protein's ability to polymerize or accumulate on bacterial surfaces suggests potential interactions between multiple CXCL6 molecules (Linge2008The). CXCL6 shares structural characteristics with defensins, known for their chemotactic and antibacterial properties, and exhibits a conserved CXC motif in the NH2-terminal region (Linge2008The).

## Function
CXCL6, also known as granulocyte chemotactic protein-2, is a chemokine involved in the recruitment and activation of neutrophils, playing a crucial role in the innate immune response. It binds with high affinity to the CXCR1 and CXCR2 receptors, which are expressed on various components of innate immunity, including neutrophils, monocytes, mast cells, and NK cells (mittal2008cxcl6; Linge2008The). CXCL6 is produced in high concentrations by mesenchymal cells, such as fibroblasts and endothelial cells, and its production is primarily induced by interleukin-1β (IL-1β) (mittal2008cxcl6; Wuyts2003The).

In healthy human cells, CXCL6 is involved in leukocyte trafficking and activation, causing cellular activation and chemotaxis. It also possesses angiogenic properties, activating endothelial cells to induce a mitogenic response, which results in angiogenesis (Linge2008The). CXCL6 is expressed in various tissues, including the heart, lung, liver, and pancreas, and plays a role in normal fetal development, with its receptors being constitutively expressed in fetal tissues (mittal2008cxcl6). Additionally, CXCL6 has been shown to possess antibacterial activity, disrupting bacterial membranes and showing higher antibacterial activity compared to other CXC chemokines (Linge2008The).

## Clinical Significance
CXCL6 plays a significant role in various diseases, particularly in cancer and inflammatory conditions. In non-small cell lung cancer (NSCLC), CXCL6 is up-regulated and interacts with miR-515-5p, a microRNA that is down-regulated in NSCLC cells treated with CXCL6. This interaction affects cell proliferation, migration, and apoptosis, suggesting that CXCL6 contributes to NSCLC progression and chemoresistance (Li2018CXCL6).

In inflammatory diseases, CXCL6 is implicated in arthritis and liver inflammation. In osteoarthritis, it stimulates inflammation by recruiting and activating immune cells. In liver inflammation, CXCL6 levels rise due to ethanol exposure, indicating its potential as a biomarker for alcoholic liver disease (Zhou2023The).

CXCL6 is also involved in the recruitment of leukocytes and modulation of the tumor microenvironment, influencing tumor cell proliferation, metastasis, and therapeutic resistance. This makes it a potential therapeutic target in various cancers, including breast cancer, kidney renal clear cell carcinoma, hepatocellular carcinoma, and ovarian cancer (Zhou2023The). The dysregulation of CXCL6 expression and its interactions can thus contribute to the progression of these diseases.

## Interactions
CXCL6, also known as granulocyte chemotactic protein 2 (GCP-2), primarily interacts with the CXCR1 and CXCR2 receptors. These interactions are crucial for its role in promoting chemotaxis and activation of neutrophils, which are key components of the immune response (mittal2008cxcl6; Linge2008The). The binding of CXCL6 to these receptors activates signaling pathways such as PI3K/AKT and β-catenin, which are involved in cell proliferation, migration, and invasion, particularly in the context of osteosarcoma cells (Liu2019Activation).

In the context of non-small cell lung cancer (NSCLC), CXCL6 interacts with microRNA miR-515-5p. CXCL6 down-regulates miR-515-5p, which acts as a tumor suppressor by targeting CXCL6 itself, suggesting a feedback loop that promotes cancer cell survival and metastasis (Li2018CXCL6). This interaction highlights the complex regulatory mechanisms involving CXCL6 in cancer progression.

CXCL6 also exhibits antibacterial properties by binding to bacterial surfaces and disrupting membranes, a function attributed to its structural features, including an amphipathic COOH-terminal α-helix (Linge2008The). This interaction underscores its role in innate immunity beyond chemotaxis.


## References


[1. (Zhou2023The) Chenjia Zhou, Ying Gao, Peilun Ding, Tao Wu, and Guang Ji. The role of cxcl family members in different diseases. Cell Death Discovery, July 2023. URL: http://dx.doi.org/10.1038/s41420-023-01524-9, doi:10.1038/s41420-023-01524-9. This article has 38 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41420-023-01524-9)

2. (mittal2008cxcl6) Pooja Mittal, Roberto Romero, Juan Pedro Kusanovic, Samuel S Edwin, Francesca Gotsch, Shali Mazaki-Tovi, Jimmy Espinoza, Offer Erez, Chia-Ling Nhan-Chang, Nandor G Than, and others. Cxcl6 (granulocyte chemotactic protein-2): a novel chemokine involved in the innate immune response of the amniotic cavity. American Journal of Reproductive Immunology, 60(3):246–257, 2008. This article has 76 citations and is from a peer-reviewed journal.

[3. (Linge2008The) Helena M. Linge, Mattias Collin, Pontus Nordenfelt, Matthias Mörgelin, Martin Malmsten, and Arne Egesten. The human cxc chemokine granulocyte chemotactic protein 2 (gcp-2)/cxcl6 possesses membrane-disrupting properties and is antibacterial. Antimicrobial Agents and Chemotherapy, 52(7):2599–2607, July 2008. URL: http://dx.doi.org/10.1128/aac.00028-08, doi:10.1128/aac.00028-08. This article has 61 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1128/aac.00028-08)

[4. (Wuyts2003The) Anja Wuyts, Sofie Struyf, Klara Gijsbers, Evemie Schutyser, Willy Put, René Conings, Jean-Pierre Lenaerts, Karel Geboes, Ghislain Opdenakker, Patricia Menten, Paul Proost, and Jo Van Damme. The cxc chemokine gcp-2/cxcl6 is predominantly induced in mesenchymal cells by interleukin-1β and is down-regulated by interferon-γ: comparison with interleukin-8/cxcl8. Laboratory Investigation, 83(1):23–34, January 2003. URL: http://dx.doi.org/10.1097/01.LAB.0000048719.53282.00, doi:10.1097/01.lab.0000048719.53282.00. This article has 111 citations and is from a peer-reviewed journal.](https://doi.org/10.1097/01.LAB.0000048719.53282.00)

[5. (Li2018CXCL6) Jun Li, Zhiyuan Tang, Haiying Wang, Wei Wu, Fengqiu Zhou, Honggang Ke, Wei Lu, Shu Zhang, Yanju Zhang, Si Yang, Songshi Ni, and Jianan Huang. Cxcl6 promotes non-small cell lung cancer cell survival and metastasis via down-regulation of mir-515-5p. Biomedicine &amp; Pharmacotherapy, 97:1182–1188, January 2018. URL: http://dx.doi.org/10.1016/j.biopha.2017.11.004, doi:10.1016/j.biopha.2017.11.004. This article has 56 citations.](https://doi.org/10.1016/j.biopha.2017.11.004)

[6. (Liu2019Activation) Guangchen Liu, Liping An, Hongmei Zhang, Peige Du, and Yu Sheng. Activation of cxcl6/cxcr1/2 axis promotes the growth and metastasis of osteosarcoma cells in vitro and in vivo. Frontiers in Pharmacology, March 2019. URL: http://dx.doi.org/10.3389/fphar.2019.00307, doi:10.3389/fphar.2019.00307. This article has 35 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphar.2019.00307)